2017 | 06 | 05

Vironova Annual General Meeting has been held

Vironova AB held its Annual General Meeting on May 31st 2107, at which the Annual report and Auditor’s report as well as the consolidated Annual report and consolidated Auditor’s report for the previous financial year were presented. The auditors report can be found below, click on Read more, or alternatively can be downloaded in pdf format HERE.
The Meeting resolved to discharge the Board Members and Managing Director from liability for the preceding financial year and the Board's request for authorization to issue shares was granted.
The meeting voted in favor of re-electing existing Board members, with the exception of Ove Mattsson, until the close of the next Annual General Meeting. Existing alternate Board members were also re-elected until the close of the next Annual General Meeting, along with the current Auditor.

Shareholders wishing to receive more information are welcome to contact
Johan Lund
Finance and Accounting Manager
Vironova AB

Mobile +46(0)7 687 12 146
johan.lund@vironova.com

News and events

Read about the latest news and events at Vironova.

  • All news
  • Inside Vironova
  • Open positions
  • Events and publications
VIEW MORE
VIEW MORE
VIEW MORE
VIEW MORE

On demand webinar

  • Title: Unmatched Viral Particle Analysis in Vaccine and Gene Therapy Development
  • Speaker: Josefina Nilsson, head of EM services & Martin Ryner, Strategic development manager
  • Watch webinar

Upcoming events 2017

Cell & Gene Therapy Europe 2017
6-7 December, Amsterdam
Booth 24

Vironova on MyNewsDesk

Follow us on MyNewsDesk and get the latest info on investor relations, events and company news.
Click here to get to our MyNewsDesk-page.

Press contact
For press enquiries, please contact
info@vironova.com

IR contact
Mohammed Homman
ceo@vironova.com